Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xamiol Gel vs Daivonex Solution in Chinese Adults with Scalp Psoriasis
NCT02533973Phase 4Completed
- Sponsor
- LEO Pharma
- Start
- Sep 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of calcipotriol + betamethasone in psoriasis (2 arms), sponsored by LEO Pharma. Primary endpoint: Safety of Xamiol gel (adverse events) at 28 weeks. Started Sep 2015; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02533973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02533973.